Literature DB >> 25630904

Increasing use of ADHD medications in pregnancy.

Carol Louik1, Stephen Kerr, Katherine E Kelley, Allen A Mitchell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25630904      PMCID： PMC4313616          DOI： 10.1002/pds.3742

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN： 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  17 in total

1.  A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.

Authors: 
Journal:  Arch Gen Psychiatry       Date:  1999-12

2.  First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.

Authors:  Carol Louik; Angela E Lin; Martha M Werler; Sonia Hernández-Díaz; Allen A Mitchell
Journal:  N Engl J Med       Date:  2007-06-28       Impact factor: 91.245

3.  First-trimester exposure to methylphenidate: a population-based cohort study.

Authors:  Anton Pottegård; Jesper Hallas; Jon T Andersen; Ellen C L Løkkegaard; Dorthe Dideriksen; Lise Aagaard; Per Damkier
Journal:  J Clin Psychiatry       Date:  2014-01       Impact factor: 4.384

Review 4.  ADHD treatment and pregnancy.

Authors:  Frank M C Besag
Journal:  Drug Saf       Date:  2014-06       Impact factor: 5.606

5.  Multivitamin supplementation and risk of birth defects.

Authors:  M M Werler; C Hayes; C Louik; S Shapiro; A A Mitchell
Journal:  Am J Epidemiol       Date:  1999-10-01       Impact factor: 4.897

6.  Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk.

Authors:  Phoebe G Thorpe; Suzanne M Gilboa; Sonia Hernandez-Diaz; Jennifer Lind; Janet D Cragan; Gerald Briggs; Sandra Kweder; Jan M Friedman; Allen A Mitchell; Margaret A Honein
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-07-29       Impact factor: 2.890

7.  Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011.

Authors:  Susanna N Visser; Melissa L Danielson; Rebecca H Bitsko; Joseph R Holbrook; Michael D Kogan; Reem M Ghandour; Ruth Perou; Stephen J Blumberg
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-11-21       Impact factor: 8.829

8.  Use of ADHD medication during pregnancy from 1999 to 2010: a Danish register-based study.

Authors:  Katia Buch Haervig; Laust Hvas Mortensen; Anne Vinkel Hansen; Katrine Strandberg-Larsen
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-03-04       Impact factor: 2.890

9.  Effect of questionnaire design on recall of drug exposure in pregnancy.

Authors:  A A Mitchell; L B Cottler; S Shapiro
Journal:  Am J Epidemiol       Date:  1986-04       Impact factor: 4.897

10.  Birth defects related to bendectin use in pregnancy. I. Oral clefts and cardiac defects.

Authors:  A A Mitchell; L Rosenberg; S Shapiro; D Slone
Journal:  JAMA       Date:  1981-06-12       Impact factor: 56.272
View more
  7 in total

1.  ADHD Medication Use During Pregnancy and Risk for Selected Birth Defects: National Birth Defects Prevention Study, 1998-2011.

Authors:  Kayla N Anderson; Annelise C Dutton; Cheryl S Broussard; Sherry L Farr; Jennifer N Lind; Susanna N Visser; Elizabeth C Ailes; Stuart K Shapira; Jennita Reefhuis; Sarah C Tinker
Journal:  J Atten Disord       Date:  2018-03-09       Impact factor: 3.256

2.  Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations: A Cohort Study From the International Pregnancy Safety Study Consortium.

Authors:  Krista F Huybrechts; Gabriella Bröms; Lotte Brix Christensen; Kristjana Einarsdóttir; Anders Engeland; Kari Furu; Mika Gissler; Sonia Hernandez-Diaz; Pär Karlsson; Øystein Karlstad; Helle Kieler; Anna-Maria Lahesmaa-Korpinen; Helen Mogun; Mette Nørgaard; Johan Reutfors; Henrik Toft Sørensen; Helga Zoega; Brian T Bateman
Journal:  JAMA Psychiatry       Date:  2018-02-01       Impact factor: 21.596

Review 3.  Pharmacological Treatment of Attention Deficit Hyperactivity Disorder During Pregnancy and Lactation.

Authors:  Asher Ornoy
Journal:  Pharm Res       Date:  2018-02-06       Impact factor: 4.200

4.  Prevalence and determinants of attention deficit/hyperactivity disorder (ADHD) medication use during pregnancy: Results from the Quebec Pregnancy/Children Cohort.

Authors:  Maxim Lemelin; Takoua Boukhris; Jin-Ping Zhao; Odile Sheehy; Anick Bérard
Journal:  Pharmacol Res Perspect       Date:  2021-05

Review 5.  The Effects of Drugs used for the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) on Pregnancy Outcome and Breast-feeding: A Critical Review.

Authors:  Asher Ornoy; Gideon Koren
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

6.  Contribution of pharmaceutical drugs of dependence to the incidence of neonatal abstinence syndrome in Western Australia between 2003 and 2018.

Authors:  Erin A Kelty; Craig N Cumming; David B Preen
Journal:  Pharmacotherapy       Date:  2022-04-04       Impact factor: 6.251

7.  Attention-Deficit/Hyperactivity Disorder Medication Prescription Claims Among Privately Insured Women Aged 15-44 Years - United States, 2003-2015.

Authors:  Kayla N Anderson; Elizabeth C Ailes; Melissa Danielson; Jennifer N Lind; Sherry L Farr; Cheryl S Broussard; Sarah C Tinker
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-19       Impact factor: 17.586
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.